Literature DB >> 1873687

The effect of cromakalim on the normal and hyper-reflexic human detrusor muscle.

D E Nurse1, J M Restorick, A R Mundy.   

Abstract

Cromakalim is a benzopyran derivative which relaxes smooth muscle, probably by opening membrane potassium channels. This study tested the effect of cromakalim on spontaneous, electrically induced and pharmacologically induced contractile activity of normal and hyper-reflexic human detrusor muscle samples. All 3 types of contractile activity were reduced in the presence of cromakalim. A preliminary clinical trial of cromakalim was conducted, the results of which also suggest that this type of drug may have a significant role in the treatment of detrusor instability and hyper-reflexia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1873687     DOI: 10.1111/j.1464-410x.1991.tb15251.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

Review 1.  K(ATP) channel therapeutics at the bedside.

Authors:  A Jahangir; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2005-07       Impact factor: 5.000

Review 2.  Electrophysiological properties of the bladder.

Authors:  C H Fry; C Wu; G P Sui
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

3.  Effect of rilmakalim on detrusor contraction in the presence and absence of urothelium.

Authors:  Melinda Wuest; Susann Kaden; Oliver W Hakenberg; Manfred P Wirth; Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-11-11       Impact factor: 3.000

4.  In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892.

Authors:  Murali Gopalakrishnan; Steven A Buckner; Char-Chang Shieh; Thomas Fey; Adebola Fabiyi; Kristi L Whiteaker; Rachel Davis-Taber; Ivan Milicic; Anthony V Daza; Victoria E S Scott; Neil A Castle; David Printzenhoff; Brecht London; Sean C Turner; William A Carroll; James P Sullivan; Michael J Coghlan; Michael E Brune
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

5.  The effect of levcromakalim (BRL 38227) on bladder function in patients with high spinal cord lesions.

Authors:  K Komersova; J W Rogerson; E L Conway; T C Lim; D J Brown; H Krum; G P Jackman; R Murdoch; W J Louis
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.